SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-19-000493
Filing Date
2019-06-04
Accepted
2019-06-03 19:02:52
Documents
3
Period of Report
2019-05-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k060319_8k.htm 8-K 17057
2 EXHIBIT 99.1 PRESS RELEASE f8k060319_ex99z1.htm EX-99.1 8974
3 IMAGE f8k0603198k1.jpg GRAPHIC 28546
  Complete submission text file 0001078782-19-000493.txt   66161
Mailing Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022
Business Address 45 ROCKEFELLER PLAZA 20TH FLOOR, STE 83 NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Filer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54296 | Film No.: 19874883
SIC: 2834 Pharmaceutical Preparations